Erratum to: Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma

By Kinugasa Hideaki  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 489-489

Springer Publishing Company

Access to resources Recommend Favorite

Surgery Versus Transarterial Chemoembolization for Solitary Large Hepatocellular Carcinoma of BCLC Stage A

By Jin Young-Joo   Lee Jin-Woo   Choi Yong-Jun   Chung Hyun   Kim Young   Lee Kun-Young   Ahn Seung   Shin Woo   Cho Soon   Jeon Yong  

Journal of Gastrointestinal Surgery, Vol. 18, Iss. 3, 2014-03 ,pp. : 555-561

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma

By Heinzow Hauke Sebastian   Meister Tobias   Nass Dominik   Kööhler Michael   Spieker Tilmann   Wolters Heiner   Domschke Wolfram   Domagk Dirk  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 2, 2011-02 ,pp. : 201-210

Informa Healthcare

Access to resources Recommend Favorite

Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization

By Kim Jeong Han   Kim Ji Hoon   Choi Jong Hwan   Kim Chung Ho   Jung Young Kul   Yim Hyung Joon   Yeon Jong Eun   Park Jong-Jae   Kim Jae Seon   Bak Young-Tae   Byun Kwan Soo  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 3, 2009-03 ,pp. : 346-357

Informa Healthcare

Access to resources Recommend Favorite

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

By  

Liver Cancer, Vol. 6, Iss. 3, 2017-05 ,pp. : 227-235

Karger

Access to resources Recommend Favorite